Sernova Corp. (TSXV:SVA)

Healthcare

Sernova Corp is a junior healthcare company that develops medical devices and instruments.

The Ontario-based healthcare company is a clinical stage company that develops regenerative medicines with therapeutic technologies to treat metabolic, hematological, and other chronic diseases.

The firm has developed Cell Pouch System™.

It is a medical device that gets implanted and balances the body through therapeutic cells that releases required nutrients in the body to solve chronic disease problems.

The product is presently undergoing clinical tests for diabetic patients, the firm says.

The cell pouch uses an immune system mechanism to protect the body from chronic health diseases such as insulin-dependent diabetes and blood disorders for a long duration of time reportedly, the clinical stage company claims.

Sernova Corp is also working on discovering and developing cellular production solutions of specific nutrients for the treatment of chronic debilitating diseases, including Parkinson’s disease, parathyroid hormone deficiency, hemophilia, and diabetes.

The Canadian company’s pipeline products are presently at a different phase of clinical trials and development. Some of the drug candidates include:

• Human Donor Islets

• Micro-encapsulated islets for diabetes

• Autograft thyroid cells for thyroid disease

• Micro-encapsulated stem cell derived cells for diabetes

• Corrected patient cells for Hemophilia A

• Allograft immune protected cells for Hemophilia A


The clinical stage company partners and collaborates to advance its clinical programs and product portfolio with various corporations, including BioteCanada, CCRM, Alliance for Regenerative Medicine, Ontario Institute for Regenerative Medicine, JDRF, and Biotechnology Innovation Organization.

In August 2020, Sernova signed an exclusive license agreement with the University of Miami to develop therapeutic cell technologies for immune protection.

In February 2021, the clinical stage firm was among Venture 50 Companies on the TSX Venture Exchange.

Apart from the Toronto Stock Exchange, it is listed on two other stock markets, namely:
• OTC Market: ‘SEOVF’

• Xetra (Frankfurt Stock Exchange- FSE): PSH

Contact Information

company address Sernova Corp. 700 Collip Circle, Ste 114 London, ON, Canada N6G 4X8

company phone519 858-5126

company email[email protected]

company websitehttps://www.sernova.com/

Similar Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK